Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play
Quick Read AKTS retains full worldwide rights to its alpha-emitting cancer platform, with $517M cash and binary Q1…
Roche enters $2 billion cancer drug agreement with Nurix Therapeutics
ZURICH, June 8 (Reuters) – Swiss pharmaceutical giant Roche has entered an exclusive licensing and collaboration agreement with…
Roche enters $2 billion cancer drug agreement with Nurix Therapeutics
Mon, June 8, 2026 at 7:50 AM UTC FILE PHOTO: The logo of Swiss drugmaker Roche is seen…
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis
PASADENA, Calif., October 21, 2025–(BUSINESS WIRE)–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that a global licensing and collaboration…
SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer’s Disease
ROCKVILLE, Md. , Jan. 12, 2026 /PRNewswire/ — SciNeuro Pharmaceuticals Logo (PRNewsfoto/SciNeuro Pharmaceuticals) SciNeuro grants Novartis an exclusive worldwide…